Casdin Capital’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-150,000
Closed -$6.6M 49
2022
Q1
$6.6M Hold
150,000
0.3% 41
2021
Q4
$9.43M Sell
150,000
-40,000
-21% -$3.39M 0.27% 44
2021
Q3
$20M Hold
190,000
0.5% 39
2021
Q2
$33.6M Hold
190,000
0.85% 29
2021
Q1
$25.4M Hold
190,000
0.76% 28
2020
Q4
$25.7M Hold
190,000
0.76% 29
2020
Q3
$15.8M Hold
190,000
0.71% 31
2020
Q2
$15.6M Hold
190,000
0.92% 29
2020
Q1
$9.78M Buy
+190,000
New +$9.9M 1.04% 28
2018
Q3
Sell
-135,000
Closed -$3.14M 38
2018
Q2
$3.14M Hold
135,000
0.44% 30
2018
Q1
$2.88M Buy
+135,000
New +$3.06M 0.51% 29

Other funds holding ZLAB

Casdin Capital's ZLAB Position: Q2 2022 in Review

Casdin Capital sold out of Zai Lab (ZLAB) in Q2 2022, closing a stake of 150,000 shares — an estimated $6.6M sold.

Casdin Capital first reported a position in ZLAB in Q1 2018 and held it in 11 quarters. The position peaked at $33.6M in Q2 2021. 164 funds tracked by Wall St. Rank hold ZLAB as of Q2 2022.

  • Casdin Capital reported no remaining Zai Lab position as of Q2 2022 after selling out during the quarter.
  • Casdin Capital sold 150,000 Zai Lab shares in Q2 2022, an estimated $6.6M.
  • Casdin Capital first reported a position in Zai Lab in Q1 2018 and held it in 11 quarters.
  • Casdin Capital's Zai Lab position peaked at $33.6M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Zai Lab as of Q2 2022.

Based on Casdin Capital's 13F filing for Q2 2022, filed 15 Aug 2022.